408 related articles for article (PubMed ID: 23760581)
1. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
[TBL] [Abstract][Full Text] [Related]
2. A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.
Lozeau DF; Farber MJ; Lee JB
J Am Acad Dermatol; 2016 Jan; 74(1):68-74. PubMed ID: 26549250
[TBL] [Abstract][Full Text] [Related]
3. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.
Kim CC; Berry EG; Marchetti MA; Swetter SM; Lim G; Grossman D; Curiel-Lewandrowski C; Chu EY; Ming ME; Zhu K; Brahmbhatt M; Balakrishnan V; Davis MJ; Wolner Z; Fleming N; Ferris LK; Nguyen J; Trofymenko O; Liu Y; Chen SC;
JAMA Dermatol; 2018 Dec; 154(12):1401-1408. PubMed ID: 30304348
[TBL] [Abstract][Full Text] [Related]
4. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.
Strazzula L; Vedak P; Hoang MP; Sober A; Tsao H; Kroshinsky D
J Am Acad Dermatol; 2014 Dec; 71(6):1071-6. PubMed ID: 25262175
[TBL] [Abstract][Full Text] [Related]
5. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
7. [Dysplastic melanocytic nevus].
Salava A; Ranki A; Saksela O
Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
[TBL] [Abstract][Full Text] [Related]
8. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
Fleming NH; Egbert BM; Kim J; Swetter SM
JAMA Dermatol; 2016 Dec; 152(12):1327-1334. PubMed ID: 27542070
[TBL] [Abstract][Full Text] [Related]
9. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
Kolman O; Hoang MP; Piris A; Mihm MC; Duncan LM
J Am Acad Dermatol; 2010 Oct; 63(4):661-7. PubMed ID: 20846568
[TBL] [Abstract][Full Text] [Related]
10. Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision.
Engeln K; Peters K; Ho J; Jedrych J; Winger D; Ferris LK; Patton T
J Am Acad Dermatol; 2017 Feb; 76(2):244-249. PubMed ID: 27838051
[TBL] [Abstract][Full Text] [Related]
11. Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.
Comfere NI; Chakraborty R; Peters MS
J Am Acad Dermatol; 2013 Nov; 69(5):687-692. PubMed ID: 23932648
[TBL] [Abstract][Full Text] [Related]
12. Dysplastic nevi and malignant melanoma.
Crutcher WA; Cohen PJ
Am Fam Physician; 1990 Aug; 42(2):372-85. PubMed ID: 2200246
[TBL] [Abstract][Full Text] [Related]
13. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
14. Negative predictive value of biopsy margins of dysplastic nevi: A single-institution retrospective review.
Duncan JR; Purnell JC; Stratton MS; Pavlidakey PG; Huang C; Phillips CB
J Am Acad Dermatol; 2020 Jan; 82(1):87-93. PubMed ID: 31326466
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of biopsies and excisions of dysplastic acral nevi: a study of 187 lesions.
Bronsnick T; Kazi N; Kirkorian AY; Rao BK
Dermatol Surg; 2014 Apr; 40(4):455-9. PubMed ID: 24456372
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
17. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
[TBL] [Abstract][Full Text] [Related]
18. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
[TBL] [Abstract][Full Text] [Related]
19. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
20. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
